REGULATORY INTELLIGENCE·Recall
Novocol Pharmaceutical Recalls 5,520 Cartons of Mepivacaine HCl 3% Injection Over Defective Cartridges
Novocol Pharmaceutical of Canada, Inc. has initiated a Class II recall for 5,520 cartons of Mepivacaine HCl 3% Injection due to defective, cracked cartridges. This voluntary action, impacting U.S. nationwide distribution, necessitates immediate supply chain review for procurement and regulatory teams. The defect poses direct patient safety risks and underscores critical quality control vulnerabilities for this essential dental anesthetic.
90-Day Activity